KRAS and pancreatic neoplasm: In pancreatic cancer, LXA4 is associated with attenuated cancer cell invasion and metastasis by inhibiting KRAS-induced ROS production, as well as ERK/MMPs and TGF-β1 signaling pathways [104,105].